Alendronate Sodium
Brand name: Alendronate Sodium
Rank #286 of 500 drugs by total cost
$41.4M
Total Cost
3,414,824
Total Claims
$41.4M
Total Cost
70,080
Prescribers
$12
Cost per Claim
813,462
Beneficiaries
7,624,245
30-Day Fills
$591
Avg Cost/Provider
49
Avg Claims/Provider
About Alendronate Sodium
Alendronate Sodium (sold as Alendronate Sodium) was prescribed 3,414,824 times by 70,080 Medicare Part D providers in 2023, costing the program $41.4M. At $12 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 283 | Topiramate (Topiramate) | $41.9M | 1,141,093 |
| 284 | Latanoprostene Bunod (Vyzulta) | $41.6M | 92,705 |
| 285 | Travoprost (Travoprost) | $41.5M | 178,599 |
| 286 | Alendronate Sodium (Alendronate Sodium) | $41.4M | 3,414,824 |
| 287 | Daptomycin (Daptomycin) | $41.2M | 41,245 |
| 288 | Pitavastatin Calcium (Livalo) | $40.8M | 69,636 |
| 289 | Bromfenac Sodium (Prolensa) | $40.8M | 121,284 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology